Hydroxyurea-induced leg ulcers: Is macroerythrocytosis a pathogenic factor?

Journal of the European Academy of Dermatology and Venereology

Volumn 12, Issue 3, 1999, Pages 243-244

  Vélez, Antonio ^a,b   Jose Maria ^a   Garcia Aranda ^a   Moreno, José Carlos ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

Hydroxyurea; Leg ulcers; Macroerythrocytosis

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; HYDROXYUREA; TICLOPIDINE;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; ERYTHROCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; LEG ULCER; MALE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN ULCER; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ANIMALS; DOGS; FEMALE; HUMANS; HYDROXYUREA; LEG ULCER; MIDDLE AGED; NUCLEIC ACID SYNTHESIS INHIBITORS; POLYCYTHEMIA; THROMBOCYTOSIS;

EID: 0032779910     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(99)00022-7     Document Type: Article

References (7)

1. Boyd AS, Neldner KH. Hydroxyurea therapy. J Am Acad Dermatol 1991;25:518-524.
2. Vêlez A, Moreno JC. Indicaciones y efectos secundarios de la hidroxiurea en dermatologia. Actas Dermosifiliogr 1997;88:511-518.
3. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975;! 11:183-187.
4. Callot-Mellot C, Bodemer C, Chosidow O, et al. Cutaneous carcinoma during long-term hydroxyurea therapy: a report of 5 cases. Arch Dermatol 1996;132:1395-1397.
5. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol 1997:36:178-182.
6. Montefusco E, Alimena G, Gastaldi R. Unusual dermatologie toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori 1986;72:317-321.
7. Pascher F, Keen R. Chronic ulcers of the leg associated with blood dyscrasias. Arch Dermatol 1952;66:478-487.